Estrogens, antiestrogens and cell proliferation
- PMID: 2662968
- DOI: 10.1002/bies.950100608
Estrogens, antiestrogens and cell proliferation
Abstract
The classical estrogen receptor model does not sufficiently account for the tumor-promoting activity of estrogens or for the antiproliferative effect of anti-estrogens in estrogen-dependent tumors. Particular difficulties not readily accommodated within the model are that hormonal autonomy can supervene without loss of the estrogen receptor and that antiestrogen effects are highly context-dependent, without apparent differences in the estrogen receptor itself or in metabolic transformation of antiestrogens. Recent studies suggest that estrogens may promote cell proliferation, in part, through the mediation of growth factors and that antiestrogens may exert some of their effects by mechanisms unrelated to the estrogen receptor.
Similar articles
-
Effect of estrogens and antiestrogens on growth of human breast cancer cells in athymic nude mice.Cancer Res. 1985 Feb;45(2):584-90. Cancer Res. 1985. PMID: 3967234
-
Proliferation, hormonal responsiveness, and estrogen receptor content of MCF-7 human breast cancer cells grown in the short-term and long-term absence of estrogens.Cancer Res. 1987 Aug 15;47(16):4355-60. Cancer Res. 1987. PMID: 3607768
-
Nonsteroidal antiestrogens are estrogen-receptor-targeted growth inhibitors that can act in the absence of estrogens.Horm Res. 1987;28(2-4):196-201. doi: 10.1159/000180944. Horm Res. 1987. PMID: 3331372 Review.
-
Antiestrogen binding in antiestrogen growth-resistant estrogen-responsive clonal variants of MCF-7 human breast cancer cells.Cancer Res. 1984 Nov;44(11):5038-45. Cancer Res. 1984. PMID: 6488162
-
Estrogen regulation of proliferation and hormonal modulation of estrogen and progesterone receptor biosynthesis and degradation in target cells.Prog Clin Biol Res. 1990;322:201-11. Prog Clin Biol Res. 1990. PMID: 2406733 Review. No abstract available.
Cited by
-
Metabolomics Analysis Discovers Estrogen Altering Cell Proliferation via the Pentose Phosphate Pathway in Infertility Patient Endometria.Front Endocrinol (Lausanne). 2021 Nov 15;12:791174. doi: 10.3389/fendo.2021.791174. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 34867831 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources